Uipath is trading 8.3% down now at $16.70 after September 3 earnings, as investors focused on cautious growth guidance and uncertain AI monetization.

  • Revenue reached $410.26 million, above the $397.77 million forecast; adjusted EPS matched at $0.15.
  • Net-new ARR was $37 million, while fiscal 2027 revenue guidance rose to $1.789–$1.794 billion.
  • Investors viewed the outlook as insufficiently aggressive amid low-teens growth.